Westside Investment Management, Inc. Bristol Myers Squibb CO Transaction History

Westside Investment Management, Inc.

$437 Billion
Q2 2024

A detailed history of Westside Investment Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Westside Investment Management, Inc. holds 7,493 shares of BMY stock, worth $398,777. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,493

Previous 6,761 10.83%

Holding current value

$398,777

Previous $366 Million 15.07%

% of portfolio

0.07%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$40.25 - $52.99 $29,463 - $38,788	732 Added 10.83%	7,493 $311 Million
Q1 2024 Apr 19, 2024	SELL	$47.98 - $54.4 $18,952 - $21,488	-395 Reduced 5.52%	6,761 $366 Million
Q4 2023 Jan 12, 2024	BUY	$48.48 - $57.85 $9,889 - $11,801	204 Added 2.93%	7,156 $367 Million
Q3 2023 Nov 15, 2023	BUY	$57.89 - $64.73 $231 - $258	4 Added 0.06%	6,952 $404 Million
Q2 2023 Jul 14, 2023	BUY	$63.71 - $70.74 $191 - $212	3 Added 0.04%	6,948 $444 Million
Q1 2023 May 17, 2023	SELL	$65.71 - $74.53 $3,876 - $4,397	-59 Reduced 0.84%	6,945 $481 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $6,642 - $7,865	-97 Reduced 1.37%	7,004 $14.9 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $128 - $75,687	-985 Reduced 12.18%	7,101 $14.7 Million
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $217 - $239	3 Added 0.04%	8,086 $622,000
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $6,455 - $7,740	-105 Reduced 1.28%	8,083 $590,000
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $13,461 - $15,692	-251 Reduced 2.97%	8,188 $510,000
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $16,271 - $19,060	-275 Reduced 3.16%	8,439 $499,000
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $100,851 - $109,827	-1,629 Reduced 15.75%	8,714 $582,000
Q1 2021 Apr 14, 2021	BUY	$59.34 - $66.74 $69,843 - $78,552	1,177 Added 12.84%	10,343 $652,000
Q4 2020 Jan 15, 2021	SELL	$57.74 - $65.43 $9,989 - $11,319	-173 Reduced 1.85%	9,166 $568,000
Q3 2020 Oct 14, 2020	BUY	$57.43 - $63.64 $134,443 - $148,981	2,341 Added 33.45%	9,339 $563,000
Q2 2020 Jul 21, 2020	SELL	$54.82 - $64.09 $14,198 - $16,599	-259 Reduced 3.57%	6,998 $411,000
Q1 2020 Apr 16, 2020	BUY	$46.4 - $67.43 $3,804 - $5,529	82 Added 1.14%	7,257 $404,000
Q2 2019 Jul 24, 2019	BUY	$44.62 - $49.34 $5,711 - $6,315	128 Added 1.82%	7,175 $325,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $15,798 - $20,486	-324 Reduced 4.4%	7,047 $366,000
Q3 2018 Nov 08, 2018	SELL	$55.19 - $62.25 $204,147 - $230,262	-3,699 Reduced 33.41%	7,371 $458 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $21,374 - $26,640	-423 Reduced 3.68%	11,070 $0
Q1 2018 Apr 16, 2018	BUY	$59.92 - $68.98 $59 - $68	1 Added 0.01%	11,493 $0
Q4 2017 Feb 15, 2018	SELL	$59.94 - $65.35 $2,337 - $2,548	-39 Reduced 0.34%	11,492 $0
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $55 - $63	1 Added 0.01%	11,531 $0
Q2 2017 Aug 15, 2017	BUY	N/A	11,530	11,530 $0

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Account

Westside Investment Management, Inc. Bristol Myers Squibb CO Transaction History